|
| |
Pathophysiology
 | most types due to defective urinary diulution, ie failure of water diuresis |
 | normal water diuresis requires 3 factors:
- suppression of ADH secretion
- sufficient sodium and water must reach diluting sites of nephron in
ascending limb of loop of Henle and distal convoluted tubule. Inadequate
delivery of Na and water to distal sites may be due to ¯
GFR and/or proximal tubular reabsorption. The
distal tubules are not absolutely impermeable to water even in the absence of
ADH, as the delivery of dilute urine falls the proportion of water that leaks
from the hypotonic tubular fluid into the isotonic cortical and slightly
hypertonic medullary fluid increases and the urine osmolality rises. This may
even lead to excretion of urine that is hypertonic to plasma, despite the
absence of ADH
- ascending loop of Henle and distal tubule must function normally,
reabsorbing Na while remaining impermeable to water |
Aetiology
Classification of hyponatraemia

With serum hyposmolality
Associated with fluid depletion
(History of fluid loss? Hypotension or ¯ skin
turgor? urea?)
- extrarenal salt and water loss. Urinary Na < 10 mmol/l
- GI (eg vomiting, diarrhoea, GI suction, fistulae)
- abdominal sequestration (eg peritonitis, rapid reaccumulation of ascites)
- skin (sweating, burns)
- renal (urinary Na > 20)
- renal disease (diuretic phase ARF, postobstructive diuresis, chronic renal
failure)
- salt-wasting (cerebral/renal)
- diuretic excess
- mineralocorticoid deficiency (1°/2°)
Associated with ECF volume excess and oedema
Associated with normal or modestly expanded ECF volume (no oedema)
Urinary Na >20 mmol/l
- acute and chronic renal failure
- temporary impairment of water diuresis (pain, drugs, emotion)
- SIADH
- endocrine (glucocorticoid deficiency, hypothyroidism)
- essential ("sick-cell syndrome")
Urinary Na <20 mmol/l
 | severe polydipsia |
Without serum hyposmolality
 | osmotic (hyperglycaemia, mannitol). Results in shift of water from cells
into extracellular fluid |
 | artifactual: hyperlipidaemia, hyperproteinaemia and laboratory error |
Types of hyponatraemia
Hyponatraemia due to volume depletion
 | impaired delivery of Na and water to ascending loop and distal tubule plus
high ADH due to volume depletion |
 | hyponatraemia per se is usually of little clinical significance. Major
features are of extracellular volume contraction |
 | reduction of Na by more than 10-15 mmol/l is rare in absence of obvious
decreases in skin turgor, postural or recumbent ¯
BP and some degree of uraemia |
 | in occasional patient with Na < 125 mmol/l may be desirable to administer
to give some of the replacement as hypertonic saline |
Hyponatraemia due to diuretics
 | multiple factors contribute to hyponatraemia
- salt loss may cause volume depletion
- thiazides and loop diuretics inhibit salt reabsorption in the diluting
segments of nephron and thereby directly limit water diuresis
- thiazides most commonly associated with ¯ Na
because they interfere with Na reabsorption in distal tubulre but, unlike loop
diuretics, do not limit urine concentration and water retention by interfering
with Na transport in the loop of Henle
- K depletion contributes to ¯ Na through
uncertain mechanisms |
 | ¯ Na due to diuretic therapy for
BP usually mild but may be moderate or severe in patients who drink large
volumes of hypotonic fluids |
 | elderly women especially prone to develop severe ¯
Na |
 | treatment is water restriction and K replacement |
 | Hyponatraemia associated with oedematous states |
 | usually associated with intravascular fluid depletion or decreased cardiac
output. This leads to decreased delivery of Na and water to ascending loop and
distal tubule |
 | decreased intravascular volume also triggers ADH secretion |
 | in some oedematous patients essential hyponatraemia may be an additional
contributing factor |
 | severity and frequency of ¯ Na correlates to
some extent with magnitude of oedema and seriousness of underlying condition |
 | ¯ Na often of little clinical significance and
principal features usually those of underlying disease |
 | symptomatic ¯ Na may occur, most often following
aggressive diuretic therapy or excessive oral or parenteral intake of dilute
fluids |
 | responds to effective therapy of underlying disease. Moderate
non-progressive ¯ Na does not usually cause
symptoms. Attempts to correct it by fluid restriction induce thirst and
discomfort without improving clinical picture or longevity |
 | fluid restriction to 1-1.5 l/day may be necessary in patients with severe or
progressive ¯ Na |
 | hypertonic saline should not be given (total body Na is high) except for
clinical manifestations of extreme ¯ Na (eg coma,
convulsions). Give frusemide concurrently to avoid expansion of ECF volume |
 | dialysis can be used to correct severe ¯ Na
without ECF volume |
SIADH
 | mainly due to water retention but urinary losses of Na may also contribute
to a mild negative Na balance |
 | characterized by:
- urine not maximally dilute even when marked hyponatraemia is induced by
water loading. In most cases urine osmolality exceeds that of plasma
- plasma creatinine and urea normal or low indicating that GFR is normal or
high
- during fluid loading (even if fluid is saline) hyponatraemia increases due
to water retention and urinary Na wasting
- hyponatraemia corrected by fluid restriction |
 | uric acid normal (as uric acid excretion tends to vary with
"effective" extracellular volume hyperuricaemia is common in volume
depletion) |
Aetiology
 | Neoplasia: especially oat cell CA lung. |
 | CNS disorders including:
- meningitis
- encephalitis
- tumours
- trauma
- stroke |
 | Pulmonary disease:
- tumours
- infections
- asthma
- COPD |
 | Drugs:
- oral hypoglycaemics: chlorpropamide, tolbutamide
- antineoplastic and immunosuppressive agents: vincristine, vinblastine,
cyclophosphamide
- psychoactive drugs: haloperidol, thioridazine, carbamazepine, amitriptyline |
Management
 | treat cause |
 | limit fluid intake. Usually 1-1.2 l/day is sufficient restriction |
 | occasionally patients who are symptomatic despite water restriction may be
treated by enhancing water excretion either by increasing solute excretion (by
taking high salt high protein diet) or by antagonizing ADH with demeclocyline
or lithium |
 | initial therapy with hypertonic saline may be appropriate in a few
symptomatic patients with marked hyponatraemia. Concurrent administration of
frusemide (which limits urinary concentration) may facilitate correction of
hyponatraemia in those patients who do not respond promptly to hypertonic
saline alone |
Essential hyponatraemia
 | thought that osmoreceptors in hypothalamus are reset to maintain a decreased
level of osmolality as though it were normal |
 | may occur in a variety of chronic illnesses (eg pulmonary TB, CCF, hepatic
cirrhosis) |
 | asymptomatic. Skin turgor, BP and renal function are normal unless altered
by the primary disease |
 | definitive diagnosis requires the demonstration of normal urinary dilution
in response to water loading, normal concentration during dehydration and
normal renal sodium excretory responses to sodium loading and restriction |
 | does not require treatment |
Clinical features
 | neurological dysfunction is principal clinical manifestation |
 | due to intracellular movement of water leading to brain cell swelling |
 | severity of symptoms related to degree of hyponatraemia and speed of
development |
 | ? women develop more severe manifestations than men |
 | in chronic cases degree of swelling is reduced by cellular volume regulatory
mechanisms: inorganic ions (eg K and Cl) and organic osmolytes (eg amino
acids) are transported out of cells |
 | lethargy, confusion, stupor, coma |
 | if hyponatraemia develops rapidly signs of hyperexcitability (eg muscle
twitching, irritability and convulsions may occur) |
 | ¯ Na rarely causes symptoms when Na > 125
mmol/l except when decrease in concentration has been rapid |
Treatment (euvolaemic hyponatraemia)
 | only patients with severe symptomatic hyponatraemia should be treated with
hypertonic saline |
 | if hyponatraemia has developed over 24 h or less hypertonic saline should be
administered in an amount calculated to increase plasma Na by no more than 1-2
mmol/l/h. If chronic increase Na by no more than 0.5-1 mmol/l/h. In either
case, do not raise Na by more than 12 mmol/l over first 24 h |
 | symptoms and clinical status, especially volume status, should be
continually reassessed |
© Charles Gomersall December 1999
|